Skip to main content

Table 2 Concomitant treatment with lanthanum carbonate during the study

From: Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trial

Use of lanthanum carbonate at baseline Use of lanthanum carbonate during the study Total, N = 83 Bixalomer, n = 43 Calcium carbonate, n = 40
Yes, N = 28 No or lacking data, n (%) 8 (28.6) 6 (40.0) 2 (15.4)
Yes, n (%) 20 (71.4) 9 (60.0) 11 (84.6)
Mean ± SD 1023 ± 647 1153 ± 796 917 ± 511
Median 750 750 750
Minimum/maximum 350/2250 429/2250 350/1875
No, N = 55 No or lacking data, n (%) 35 (63.6) 16 (57.1) 19 (70.4)
Yes, n (%) 20 (36.4) 12 (42.9) 8 (29.6)
Mean ± SD 864 ± 522 831 ± 637 914 ± 311
Median 750 750 781
Minimum/maximum 250/2250 250/2250 500/1375
  1. Abbreviation: SD standard deviation